CBID Recent News
Current News
Fehr on KU Biology's Interview With a Biologist podcast
Dr. Anthony Fehr was featured in the newest Interview With a Biologist podcast.
Dr. Michael Wang, CBID Pilot Project investigator, speaks about the Lab2Market Accelerator
Inside a lab, innovation can feel both exciting and uncertain. But for KU researchers, discovery may only be the beginning. Turning ideas into companies that create jobs, technologies, and growth in Kansas takes more than data—it takes courage, guidance, and a community that believes in what’s possible.
Orozco lab overturns the idea that a “risk gene” carried by millions of people influences production of Type 1 interferon in the immune system.
A new paper from the University of Kansas overturns the idea that a “risk gene” carried by millions of people worldwide influences production of Type 1 interferon, a workhorse of the immune system. ...
Fehr research shows human gene PARP14 could be novel target for viral diseases or immune-mediated disorders
Researchers at the University of Kansas have discovered a human gene, the protein PARP14, plays a role in regulating interferon, part of the body’s innate immune system. Their study, appearing in journal mBio, could guide development of antiviral therapies for several groups of viral infection. ...